Feed MTSFY
MT

Mitsui Fudosan Co., Ltd. MTSFY OTC · Real estate · Japan

$29.46 -1.04% -$0.31

Summary

67 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 8.2% a year over the last 3 years.
  • It has been profitable 6 years in a row.

What to watch

  • It cut its dividend by 34% last year.
  • The share price is above the Bulios Fair Price.
  • Out of every 100 JPY of revenue, only 10 JPY is left as net profit.
  • It earns only 2.6 JPY a year on every 100 JPY of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Overvalued Price today $29.46

By our assumptions the business is worth less than its shares cost today.

P/E today 15.7 0.5% higher
5-year average P/E 15.6
P/E today 15.7
Real Estate - Diversified industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 15.7 JPY for 1 JPY of yearly profit. Over the last five years it was 15.6 JPY on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 7.4% a year over 5 years. Over the last 3 years it grew by 8.2% a year.

Growth in detail

Does it make money?

Poorly

Where 100 JPY of revenue goes

Net profit, industry median (Real Estate - Diversified) 12 JPY

Out of every 100 JPY of revenue, 10 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
2.34%
Paid out of profit
37%

You receive $0.69 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy